Cell biologists at Jefferson Medical College and the Kimmel Cancer Center of Thomas Jefferson University in Philadelphia have found that the protein fragment endorepellin blocks both skin and lung cancer tumors from progressing in animal models by preventing their ability to recruit new blood vessels, a process called angiogenesis. They showed that endorepellin has surprisingly powerful effects on halting a cancer tumor's ability to move about and spread.
The researchers believe that these latest findings, appearing November 15, 2006 in the Journal of the National Cancer Institute, could lead to a new type of tumor inhibitor that might be used to prevent cancer from spreading to other areas in the body.
The researchers, led by Renato Iozzo, M.D., professor of pathology, anatomy and cell biology at Jefferson Medical College of Thomas Jefferson University, used two animal models of cancer to study squamous cell carcinoma and lung carcinoma. When they injected animals with artificially created "recombinant" endorepellin, they discovered that it blocked tumor growth, metabolism and angiogenesis. They also found for the first time that endorepellin targets the tumor endothelial cells, blocking the creation of new blood vessels.
"These findings have major implications for cancer treatments for a range of solid tumors such as lung, prostate and breast," Dr. Iozzo says. "All of these tumors depend on angiogenesis, so we think this could be an effective adjuvant therapy for cancer."
Endorepellin is part of the protein perlecan, which plays fundamental roles in vascular biology as scaffolding for blood vessel formation in development. In cancer, perlecan not only regulates growth factor activity, but also is a barrier to invading cancer cells.
Anti-angiogenesis drugs were all the rage in the late 1990s, when animal studies showed two drugs seemingly "melting" tumors in mice. But disappointing human clinical trials since then have scaled back expectations, and most now see such drugs as part of a treatment milieu that includes surgery, chemotherapy and radiation. More recent study results, however, Dr. Iozzo says, have renewed interest in the drugs' potential.
Dr. Iozzo says that these results suggest that endorepellin might be used to help prevent metastatic cancer spread in patients who have had a primary tumor removed. "It could be used preventatively and for maintenance, and in combination with other drugs," he notes.
"While endorepellin prevents the formation of the original blood vessels in tumor development, I think it would be more effectively used after the tumor has formed and cells try to migrate and spread," Dr. Iozzo says. The researchers are hoping to begin clinical testing of endorepellin in the near future.
Steve Benowitz | EurekAlert!
'Lipid asymmetry' plays key role in activating immune cells
20.02.2018 | Biophysical Society
New printing technique uses cells and molecules to recreate biological structures
20.02.2018 | Queen Mary University of London
For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.
In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...
Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale
Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...
For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.
But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...
Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.
The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...
Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters
Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...
15.02.2018 | Event News
13.02.2018 | Event News
12.02.2018 | Event News
20.02.2018 | Life Sciences
20.02.2018 | Medical Engineering
20.02.2018 | Physics and Astronomy